Tracking every rollback, reversal, and overreach — and the path back to the America we know.
Executive Order 14196 was signed on February 3, 2025, directing the establishment of a U.S. sovereign wealth fund to manage federal financial assets. The order specifies the fund's structure, governance, and investment parameters. The confirmed direct impact on Americans includes potential changes to how federal assets are managed and allocated, though implementation details and timeline remain in early stages.
President Trump signed legislation funding the Department of Homeland Security, ending an 11-week partial government shutdown. The bill funds most DHS agencies including the Secret Service, Coast Guard, TSA, and FEMA, with the exception of immigration enforcement agencies which Republicans plan to address separately. The shutdown's end restores full operations across critical homeland security functions.
A federal court blocked the CIA and Office of the Director of National Intelligence from firing 19 intelligence officers at the start of Trump's second term, halting what appeared to be a targeted removal of personnel involved in diversity initiatives. The ruling preserves employment protections for officers whose work included equity programs. The decision represents a judicial check on executive authority to summarily remove career intelligence personnel.
President Trump invoked the Defense Production Act to force U.S. companies to increase weapons and munitions production. Defense Secretary Pete Hegseth simultaneously pitched Congress for $350 billion to replenish military stockpiles. The action prioritizes defense manufacturing capacity and accelerates weapons output through federal authority.
The Trump administration's Department of Health and Human Services Inspector General revoked federal certification and cut $3 million in funding to Hawaii's Medicaid Fraud Control Unit after the state failed to secure indictments or convictions over four years. The defunding removes oversight capacity for detecting and prosecuting Medicaid fraud, potentially exposing the program to increased waste and abuse. Hawaii's healthcare system and Medicaid beneficiaries face reduced fraud accountability and protection of federal healthcare dollars.
The Trump administration rescinded the 2009 EPA endangerment finding that established CO2 and other greenhouse gases as threats to public health and welfare—the scientific foundation for virtually all U.S. climate regulations. This rollback eliminates federal authority to regulate planet-warming pollution and toxic emissions. Eighteen young Americans filed suit demanding immediate court intervention to protect their constitutional rights to life and liberty.
The Trump administration dismantled FDA restrictions on the vaping industry by granting marketing authorization to four flavored vaping products and issuing guidance permitting unauthorized vapes to remain on the market. The action removes regulatory guardrails that had limited industry growth and reflects tobacco industry influence over federal policy. The policy directly impacts public health protections, youth vaping rates, and the commercial vaping market.
On February 1, 2025, President Trump signed Executive Order 14193 imposing duties on goods crossing the northern U.S. border, stated as a measure to address illicit drug flows. The order establishes tariffs on northern border trade. Direct impacts on Americans include potential increased costs for goods imported from Canada and potential changes to cross-border trade operations.
On February 1, 2025, President Trump signed Executive Order 14194 imposing duties on imports from Mexico and Canada, citing the situation at the southern border. The order directs the implementation of tariffs on goods crossing the U.S.-Mexico and U.S.-Canada borders. The confirmed direct impact includes increased prices on imported goods for American consumers and businesses that rely on cross-border trade.
Executive Order 14195 was signed on February 1, 2025, directing the imposition of duties on synthetic opioids and precursor chemicals sourced from China. The order establishes tariffs and trade restrictions on these substances to disrupt supply chains. The confirmed direct impact includes increased costs for pharmaceutical manufacturers and potential effects on opioid medication availability and pricing for Americans.